Quattro Financial Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,000
| Closed | -$486K | – | 85 |
|
|
2023
Q1 | $486K | Sell |
5,000
-5,000
| -50% | -$486K | 0.2% | 61 |
|
|
2022
Q4 | $1.03M | Hold |
10,000
| – | – | 0.41% | 39 |
|
|
2022
Q3 | $848K | Hold |
10,000
| – | – | 0.34% | 45 |
|
|
2022
Q2 | $829K | Sell |
10,000
-2,000
| -17% | -$166K | 0.28% | 48 |
|
|
2022
Q1 | $925K | Hold |
12,000
| – | – | 0.31% | 52 |
|
|
2021
Q4 | $1.06M | Hold |
12,000
| – | – | 0.37% | 55 |
|
|
2021
Q3 | $901K | Hold |
12,000
| – | – | 0.24% | 64 |
|
|
2021
Q2 | $954K | Hold |
12,000
| – | – | 0.25% | 62 |
|
|
2021
Q1 | $958K | Buy |
+12,000
| New | +$958K | 0.22% | 68 |
|